| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |